
AMEXHealthcareMedical - Devices
أحدث البيانات المتاحة
0.138 US$
−0.004 US$ · -2.82%
Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore. The company's product portfolio encompasses several specialized offerings: Optonano, which provides users with the ability to view both live and static images, enabling the assembly of high-quality visual data for larger sample regions. PT-Industrial, a versatile tool utilized across various applications including material analysis, fault identification, basic measurement tasks, quality control, inspection, and general manufacturing processes. PT-Metrology, which delivers accurate dimensional measurements through a straightforward, single-button operation. PT-Biology, designed to generate the specific types of imagery required by the biomedical field. PT-Stereo, a stereo microscope that produces crisp, magnified three-dimensional views, especially effective for examining solid or thicker samples. And PT-Zoom, which enhances visual understanding by providing a magnified 3D perspective of specimens. Beyond its hardware, the firm also furnishes specialized software. Its diverse clientele includes manufacturing enterprises, healthcare service providers in the biomedical sector, and various research and development organizations. Phaos Technology Holdings was founded in 2017 and maintains its corporate headquarters in Singapore.
الإغلاق السابق
0.138 US$
−0.004 US$ · -2.82%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore. The company's product portfolio encompasses several specialized offerings: Optonano, which provides users with the ability to view both live and static images, enabling the assembly of high-quality visual data for larger sample regions. PT-Industrial, a versatile tool utilized across various applications including material analysis, fault identification, basic measurement tasks, quality control, inspection, and general manufacturing processes. PT-Metrology, which delivers accurate dimensional measurements through a straightforward, single-button operation. PT-Biology, designed to generate the specific types of imagery required by the biomedical field. PT-Stereo, a stereo microscope that produces crisp, magnified three-dimensional views, especially effective for examining solid or thicker samples. And PT-Zoom, which enhances visual understanding by providing a magnified 3D perspective of specimens. Beyond its hardware, the firm also furnishes specialized software. Its diverse clientele includes manufacturing enterprises, healthcare service providers in the biomedical sector, and various research and development organizations. Phaos Technology Holdings was founded in 2017 and maintains its corporate headquarters in Singapore.
نطاق اليوم
السعر الحالي 0.138 US$
نطاق 52 أسبوعًا
السعر الحالي 0.138 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
بيع قوي
تقييم
10
مبالغ في سعره
المشاعر
51
مختلط
المخاطر
86
مخاطر قصوى
الزخم
19
هبوط قوي
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore. The company's product portfolio encompasses several specialized offerings: Optonano, which provides users with the ability to view both live and static images, enabling the assembly of high-quality visual data for larger sample regions. PT-Industrial, a versatile tool utilized across various applications including material analysis, fault identification, basic measurement tasks, quality control, inspection, and general manufacturing processes. PT-Metrology, which delivers accurate dimensional measurements through a straightforward, single-button operation. PT-Biology, designed to generate the specific types of imagery required by the biomedical field. PT-Stereo, a stereo microscope that produces crisp, magnified three-dimensional views, especially effective for examining solid or thicker samples. And PT-Zoom, which enhances visual understanding by providing a magnified 3D perspective of specimens. Beyond its hardware, the firm also furnishes specialized software. Its diverse clientele includes manufacturing enterprises, healthcare service providers in the biomedical sector, and various research and development organizations. Phaos Technology Holdings was founded in 2017 and maintains its corporate headquarters in Singapore.
نطاق اليوم
السعر الحالي 0.138 US$
نطاق 52 أسبوعًا
السعر الحالي 0.138 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (SGD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|
| الإيرادات | 132.08 ألف SGD | 167.71 ألف SGD | 1.88 مليون SGD | 650.8 ألف SGD |
| تكلفة البضاعة المباعة | 114.77 ألف SGD | 130.64 ألف SGD | 985.1 ألف SGD | 536.17 ألف SGD |
| الربح الإجمالي | 17.31 ألف SGD | 37.07 ألف SGD | 897.7 ألف SGD | 114.63 ألف SGD |
| البحث والتطوير | — | 139.72 ألف SGD | 90.57 ألف SGD | 26.96 ألف SGD |
| مصاريف البيع والمصاريف العمومية والإدارية | 4.02 مليون SGD | 3.28 مليون SGD | 2.09 مليون SGD | 1.59 مليون SGD |
| نفقات التشغيل | 6.32 مليون SGD | 5.32 مليون SGD | 3.4 مليون SGD | 2.16 مليون SGD |
| دخل الفوائد | 225 SGD | 5.83 ألف SGD | — | — |
| مصاريف الفوائد | 9.17 ألف SGD | 8.46 ألف SGD | 43.54 ألف SGD | 25.07 ألف SGD |
| الاستهلاك والإطفاء | 160.85 ألف SGD | 186.96 ألف SGD | 176.71 ألف SGD | 195.64 ألف SGD |
| الدخل التشغيلي | −6.3 مليون SGD | −5.28 مليون SGD | −2.5 مليون SGD | −2.04 مليون SGD |
| صافي الدخل | −6.16 مليون SGD | −5.14 مليون SGD | −2.36 مليون SGD | −1.67 مليون SGD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
| الإجراء | تاريخ النفاذ | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
تقسيم الأسهمالقادمة | 12 أكتوبر 2026 | 1:15 | — | — |
ساري 12 أكتوبر 2026
1:15
المحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.